Capital intensity remains a major headwind, with CapEx/Revenue ratios reaching as high as 65.7% in 2025Q1, contributing to erratic free cash flow performance.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Cash from Operations | 2.74M | 3.1B | 167K | 5.72M | 7.24M | 6.27M | 9.74M | 8.05M | 8.06M | 7.85M | 8.38M | 8.55M | 6.77M | 8.08M | 6.87M | 6.82M | 7.18M | 7.7M | 8.95M | 8.48M | 9.16M | 8.48M | 7.61M | 8.14M | 4.19M | 4.17M | 2.52M | 3.59M | 7.73M | 7.27M | 8.8M |
| Operating CF Margin % | - | 11031.98% | 0.59% | 26.81% | 36.64% | 35.55% | 54.63% | 39.05% | 40.89% | 40.16% | 44.8% | 51.66% | 43.93% | 45.93% | 40.3% | 30.71% | 43.08% | 45.94% | 46.85% | 37.5% | 44.95% | 46.51% | 46.42% | 50.32% | 31.33% | 35.43% | 26.94% | 50.13% | 21.99% | 19.56% | 23.78% |
| Operating CF Growth % | -245.98% | 1854989.82% | -97.08% | -20.97% | 15.45% | -35.69% | 21.1% | -0.19% | 2.66% | -6.27% | -1.99% | 26.21% | -16.13% | 17.54% | 0.7% | -5.03% | -6.75% | -13.89% | 5.46% | -7.42% | 8.07% | 11.46% | -6.54% | 94.36% | 0.53% | 65.65% | -29.89% | -53.6% | 6.33% | -17.38% | 79.59% |
| Net Income | -1.54M | -2.73B | 1.53M | 265K | 1.55M | 194K | -7.72M | 1.43M | 1.63M | 2.94M | 2.25M | -576K | -562K | -113K | 813K | 1.49M | 806K | 466K | 477K | 951K | 1.66M | 1.77M | 1.99M | 1.38M | 1.1M | 1.07M | 1.31M | 2.71M | 20.05M | 1.52M | -400K |
| Depreciation & Amortization | 5.71B | 5.71B | 6.17M | 5.17M | 4.78M | 5.28M | 6.97M | 7.41M | 6.82M | 6.68M | 6.33M | 6.19M | 6.38M | 6.41M | 6.1M | 6.27M | 6M | 6.49M | 6.71M | 6.11M | 5.96M | 5.5M | 4.89M | 4.31M | 3.53M | 3M | 2.36M | 1.62M | 6.09M | 6.75M | 7M |
| Stock-Based Compensation | 403.81M | 404M | 373K | 389K | 399K | 0 | 299K | 230K | 223K | 323K | 215K | 226K | 138K | 88K | 74K | 125K | 110K | 135K | 137K | 69M | 39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | -809M | -809M | -359K | -759K | 344K | 60K | -2.16M | -444K | 48K | -1.27M | 772K | 298K | 76K | 59K | 25K | 76K | 168K | 409K | 365K | 536K | 852K | 121K | 264K | 669K | 207K | 383K | 0 | 0 | -164K | 0 | 0 |
| Other Non-Cash Items | -2.58B | 515.91M | -607K | 952K | 450K | 1.58M | 8.54M | 361K | 39K | 707K | 526K | 2.11M | 517K | 1.19M | -127K | -72K | 110K | 1K | 795K | -67.61M | -37.64M | 1.13M | 983K | 928K | 3K | 0 | -25K | -385K | -20.48M | -821K | -100K |
| Working Capital Changes | -70K | 85K | -6.95M | -294K | -296K | -853K | 3.82M | -941K | -696K | -1.53M | -1.71M | 301K | 221K | 438K | -10K | -1.07M | 99K | 201K | 458K | -503K | -663K | -36K | -516K | 848K | -653K | -288K | -1.13M | -356K | 2.23M | -182K | 2.3M |
| Change in Receivables | -1.68M | -559K | -6.94B | -719K | 696K | -519K | 2.97M | -1.19M | -420K | -860K | -1.23M | 178K | 1.07M | -643K | 655K | -961M | 0 | 573M | 686M | -786M | -331M | -1.07B | -483M | 104M | -202M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 328K | -955K | 2.23B | -79K | 608K | 851K | 263K | 28K | 115K | 125M | -199M | 175K | -859M | 1.02B | -349M | 957M | 0 | -262M | -214M | 179M | -120M | 938M | 104M | 318M | -376M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -3.66M | -7.63B | -7.11M | -6.27M | -388K | -1.67M | -2.39M | -990K | -1.53M | -653K | -1.61M | -1.93M | -4.45M | -1.72M | -6.67M | -4.14M | -315K | -10.14M | 830K | -15.67M | -4.75M | -12.57M | -1.32M | -731K | -1.06M | -714K | -277K | 629K | 11.64M | -223K | -300K |
| Capital Expenditures | -3.66M | -7.63B | -7.94M | -6.27M | -388K | -1.67M | -455K | -990K | -1.58M | -803K | -1.61M | -1.92M | -5.21M | -1.71M | -6.63M | -5.61M | -315K | -1.15M | -4.31M | -16.33M | -5.15M | -6.2M | -368K | -731K | -1.35M | -724K | -542K | -131K | -746K | -349K | -300K |
| CapEx % of Revenue | 12.6% | 27184.67% | 28.01% | 29.42% | 1.97% | 9.5% | 2.55% | 4.8% | 8% | 4.11% | 8.62% | 11.58% | 33.81% | 9.72% | 38.91% | 25.26% | 1.89% | 6.83% | 22.58% | 72.2% | 25.24% | 33.98% | 2.25% | 4.52% | 10.07% | 6.16% | 5.81% | 1.83% | 2.12% | 0.94% | 0.81% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | -2.08M | 0 | 0 | 150K | 7K | 0 | 768K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.33B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 833K | 0 | 0 | 0 | 150K | 0 | 51K | 150K | 0 | -10K | 1.36B | -14K | -31K | 1.51M | 0 | -9B | 1.47M | -617K | 20K | -7.33B | -957M | 0 | 283K | 10K | 265K | 760K | 12.39M | 126K | -100K |
| Cash from Financing | -5.35M | -3.03B | 4.41M | 1.91M | -2.66M | -655K | -4.81M | -7.07M | -7.25M | -7.92M | -6.1M | -5.47M | -3.16M | -6.02M | -1.22M | -1.54M | -6.26M | -7.01M | -5.83M | 9.57M | -1.76M | -2.73M | -8.47M | -7.02M | -4.78M | -4.29M | -2.72M | -2.43M | -8.28M | -7.4M | -8.6M |
| Debt Issued (Net) | -5.21M | -3.01M | 4.63M | 2.12M | -2.03M | 255K | -4.05M | -6.17M | -6.56M | -7.27M | -6M | -13.85M | -4.13M | -5.41M | -631K | -542K | -5.64M | -8.33M | -4.59M | 11.31M | -17K | -404K | -1.43M | -579K | -4.43M | -3.35M | -2.28M | -1.2M | -8.2M | -7.4M | -8.6M |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 5K | 5K | 0 | 0 | 0 | 0 | 220K | 0 | 1.8M | 0 | -28K | 0 | 0 | -271K | -443K | 0 | 5K | -513K | -5K | 11K | 91K | -580K | -443K | -1.2M | -2K | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -715K | -954K | -1.81M | -1.1M | -610K | -438K | -361K | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2K | 0 | -28K | 0 | -443M | -271K | -443K | 0 | 0 | -670K | -45K | -14K | -135K | -596K | -443K | -1.2M | -2K | 0 | 0 |
| Other Financing | -146K | -3.02B | -221K | -211K | -630K | -915K | -761K | -897K | -690K | -551K | -692K | 7.36M | -834K | -608K | -563K | -996K | -627K | 1.59M | -798K | -1.03M | -798K | -912K | -7.04M | -5.84M | 0 | 0 | 0 | -27K | -73K | 0 | 0 |
| Net Change in Cash | -6.27M | -7.56B | -2.53M | 1.35M | 4.19M | 3.94M | 2.55M | -13K | -710K | -719K | 662K | 1.15M | -850K | 345K | -1.02M | 1.14M | 605K | -9.45M | 3.95M | 2.39M | 2.65M | -6.82M | -2.19M | 388K | -1.66M | -841K | -482K | 1.79M | 11.1M | -351K | -8.6M |
| Free Cash Flow | -916K | -4.54B | -7.77M | -555K | 6.85M | 4.59M | 9.29M | 7.06M | 6.49M | 7.05M | 6.77M | 6.63M | 1.56M | 6.37M | 237K | 1.21M | 6.87M | 6.56M | 4.63M | -7.85M | 4.02M | 2.29M | 7.24M | 7.41M | 2.84M | 3.44M | 1.97M | 3.46M | 6.99M | 6.92M | 8.5M |
| FCF Margin % | -3.15% | -16152.7% | -27.42% | -2.6% | 34.68% | 26.06% | 52.08% | 34.25% | 32.9% | 36.05% | 36.18% | 40.08% | 10.13% | 36.2% | 1.39% | 5.45% | 41.19% | 39.12% | 24.26% | -34.7% | 19.71% | 12.53% | 44.18% | 45.8% | 21.26% | 29.27% | 21.13% | 48.3% | 19.87% | 18.62% | 22.97% |
| FCF Growth % | 85.31% | -58270.87% | -1300.18% | -108.11% | 49.07% | -50.56% | 31.64% | 8.82% | -8.01% | 4.2% | 2.02% | 324.86% | -75.48% | 2586.08% | -80.41% | -82.38% | 4.73% | 41.54% | 159.04% | -295.35% | 75.84% | -68.44% | -2.28% | 160.7% | -17.43% | 74.46% | -42.91% | -50.52% | 0.91% | -18.56% | 80.85% |
| FCF per Share | -0.14 | -685.61 | -1.16 | -0.09 | 1.09 | 0.76 | 1.50 | 1.19 | 1.08 | 1.21 | 1.24 | 1.22 | 0.31 | 1.43 | 0.05 | 0.26 | 1.49 | 1.40 | 0.93 | -1.57 | 0.80 | 0.45 | 1.42 | 1.54 | 0.59 | 0.97 | 0.51 | 0.87 | 1.46 | 1.10 | 1.70 |
| FCF Conversion (FCF/Net Income) | 0.59x | -1994.85x | 0.08x | 9.37x | 5.45x | 32.30x | -1.38x | 12.21x | 7.88x | 4.08x | 9.01x | -5.62x | -7.11x | -25.88x | 180.82x | 13.48x | 126.04x | -40.98x | 18.76x | 8.92x | 5.53x | 4.80x | 3.83x | 5.89x | 3.80x | 3.90x | 1.92x | 1.33x | 0.39x | 4.78x | -22.00x |
| Interest Paid | 606K | 1.38M | 1.4M | 1.07M | 722K | 0 | 938K | 1.32M | 1.61M | 1.57M | 2.15M | 1.67M | 2.07M | 2.12M | 2.35M | 2.5M | 2.45M | 2.35M | 2.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 474K | 739K | 1.85M | 297K | 169K | 0 | 339K | 397K | 459K | 126K | 266K | 25K | 41K | 44K | 158K | 90K | 88K | 31K | 261K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital intensity versus utilization
As reported in recent financial statements, the persistent gap between net income and operating cash flow suggests that AMS relies heavily on non-cash adjustments, with OCF/NI ratios frequently reaching extreme levels, such as the -3.51 observed in 2026Q1, indicating poor quality of earnings.
The frequent divergence between accounting losses and operating cash flow highlights a reliance on significant depreciation and amortization to mask underlying operational cash burn. Investors should monitor whether this pattern reflects a structural inability to convert clinical service revenue into actual liquidity.
Based on the company's quarterly filings, free cash flow remains highly erratic, swinging from a positive $2.1M in 2026Q1 to a deep deficit of -$4.4M in 2024Q4, reflecting the lumpy nature of capital expenditures relative to the company's limited revenue base.
The inability to maintain consistent positive free cash flow suggests that the current business model is highly sensitive to the timing of equipment maintenance and upgrades. This volatility complicates long-term financial planning and may necessitate external financing to sustain operations.
According to historical data, AMS maintains a high capital intensity, with CapEx/Revenue ratios occasionally exceeding 50%, such as the 65.7% recorded in 2025Q1, which underscores the heavy burden of maintaining specialized medical equipment in a low-growth environment.
The high proportion of revenue directed toward capital expenditures suggests that the company is trapped in a cycle of constant reinvestment just to maintain its existing fleet. This capital-heavy profile limits the firm's ability to pivot toward higher-margin growth opportunities without further straining its cash reserves.
As evidenced by the quarterly cash flow data, working capital changes have been a significant source of volatility, with swings ranging from a $1.7M inflow in 2025Q1 to a $4.0M outflow in 2023Q4, suggesting inconsistent efficiency in managing receivables and payables.
These sharp fluctuations in working capital may indicate challenges in the timing of collections from hospital partners or potential inefficiencies in inventory management for specialized parts. Such instability in cash conversion cycles warrants further investigation into the company's underlying credit and payment terms.
Quick answers to the most common questions about buying AMS stock.
American Shared Hospital Services (AMS) generated $3.10B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
American Shared Hospital Services (AMS) reported negative free cash flow of $4.54B in 2025, indicating capital requirements exceeded cash from operations.
American Shared Hospital Services (AMS) spent $7.63B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.